Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy
Article in Frontiers in Immunology (March 2021)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination in vivo and Promote Dominance of FOXP3+ Tregs in vitro
Article in Frontiers in Immunology (September 2020)
Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells
Article in Cellular Immunology (July 2020)